Evidence map›Paper›PMID 33070219›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2022

Serum potassium dynamics during acute heart failure hospitalization.

Pedro Caravaca Perez, José R González-Juanatey, Jorge Nuche, Laura Morán Fernández, David Lora Pablos, Jesús Alvarez-García, Ramón Bascompte Claret, Manuel Martínez Selles, Rafael Vázquez García, Luis Martínez Dolz and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Reply to G. Betts's letter referring to "Serum potassium dynamics during acute heart failure hospitalization".Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Pedro Caravaca PerezCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
José R González-JuanateyCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Jorge NucheCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Laura Morán FernándezCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
David Lora PablosInstituto de Investigación Sanitaria Hospital 12 Octubre (imas12), Universidad Complutense de Madrid, CIBERESP, Madrid, Spain.
Jesús Alvarez-GarcíaCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Ramón Bascompte ClaretHospital Universitari Arnau de Vilanova, IBRLLEIDA, Lleida, Spain.
Manuel Martínez SellesCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Rafael Vázquez GarcíaUGC de Cardiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Luis Martínez DolzCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Marta Cobo-MarcosCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Domingo Pascual FigalCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Maria G Crespo-LeiroCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Julio Nuñez VillotaCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Juan Cinca CuscullolaCentro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Juan F DelgadoCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. juan.delgado@salud.madrid.org.ORCID http://orcid.org/0000-0002-5401-8324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAvailable information about prognostic implications of potassium levels alteration in the setting of acute heart failure (AHF) is scarce.

objectivesWe aim to describe the prevalence of dyskalemia (hypo or hyperkalemia), its dynamic changes during AHF-hospitalization, and its long-term clinical impact after hospitalization.

methodsWe analyzed 1779 patients hospitalized with AHF who were included in the REDINSCOR II registry. Patients were classified in three groups, according to potassium levels both on admission and discharge: hypokalemia (potassium < 3.5 mEq/L), normokalemia (potassium = 3.5-5.0 mEq/L and, hyperkalemia (potassium > 5 mEq/L).

resultsThe prevalence of hypokalemia and hyperkalemia on admission was 8.2 and 4.6%, respectively, and 6.4 and 2.7% at discharge. Hyperkalemia on admission was associated with higher in-hospital mortality (OR = 2.32 [95% CI: 1.04-5.21] p = 0.045). Among patients with hypokalemia on admission, 79% had normalized potassium levels at discharge. In the case of patients with hyperkalemia on admission, 89% normalized kalemia before discharge. In multivariate Cox regression, dyskalemia was associated with higher 12-month mortality, (HR = 1.48 [95% CI, 1.12-1.96], p = 0.005). Among all patterns of dyskalemia persistent hypokalemia (HR = 3.17 [95% CI: 1.71-5.88]; p < 0.001), and transient hyperkalemia (HR = 1.75 [95% CI: 1.07-2.86]; p = 0.023) were related to reduced 12-month survival.

conclusionsPotassium levels alterations are frequent and show a dynamic behavior during AHF admission. Hyperkalemia on admission is an independent predictor of higher in-hospital mortality. Furthermore, persistent hypokalemia and transient hyperkalemia on admission are independent predictors of 12-month mortality.

Indexed as

Heart FailureHyperkalemiaHypokalemiaHospitalizationHumansPotassiumPotassiumDyskalemiaHeart failureHyperkalemiaHypokalemiaPotassium

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.